Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) Shares Outstanding (Weighted Average) (2019 - 2025)

Preaxia Health Care Payment Systems' Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $19.8 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $19.8 million; the TTM value through Aug 2025 reached $19.8 million, changed 0.0%, while the annual FY2025 figure was $19.8 million, 0.0% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $19.8 million at Preaxia Health Care Payment Systems, roughly flat from $19.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $19.8 million in Q3 2021 and bottomed at $19.8 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $19.8 million (2021), against an average of $19.8 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) grew 0.51% in 2021 before it fell 0.15% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $19.8 million in 2021, then changed by 0.0% to $19.8 million in 2022, then changed by 0.0% to $19.8 million in 2023, then changed by 0.0% to $19.8 million in 2024, then changed by 0.0% to $19.8 million in 2025.
  • Per Business Quant, the three most recent readings for PAXH's Shares Outstanding (Weighted Average) are $19.8 million (Q3 2025), $19.8 million (Q2 2025), and $19.8 million (Q1 2025).